Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | XDH | P47989 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | ACACB | O00763 | 1/20 | 0.40 |
| ▸ | ACACA | Q13085 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4978800 | 0.94 | NPC1 (0.46) | L3MBTL1NR1I2ALDH2MAOAMAOB | |
| SCHEMBL14036384 | 0.93 | S1PR1 (0.43) | L3MBTL1NR1I2ALDH2MAOAMAOB | |
| SCHEMBL29354712 | 0.91 | KMT2A (0.51) | MEN1KMT2AMAPTLMNAKDM4E | |
| SCHEMBL580702 | 0.91 | MEN1 (0.47) | L3MBTL1ALDH2MAOAMAOBNPC1 | |
| SCHEMBL17993725 | 0.91 | MAPT (0.47) | MAOAMAOBALDH1A1RECQLGAA | |
| SCHEMBL626750 | 0.91 | KMT2A (0.51) | MEN1KMT2AMAPTLMNAKDM4E | |
| SCHEMBL18012057 | 0.91 | MAPK1 (0.46) | NR1I2ALDH2MAOAMAOBNPC1 | |
| SCHEMBL4977473 | 0.91 | NPC1 (0.51) | L3MBTL1NPC1ALDH1A1GAAMEN1 | |
| SCHEMBL29356875 | 0.91 | MEN1 (0.47) | L3MBTL1ALDH2MAOAMAOBNPC1 | |
| SCHEMBL5859406 | 0.91 | MAPT (0.49) | ALDH1A1RECQLGAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1451248-B1 | 2-HYDROXYPHENYL-S-TRIAZINE CROSSLINKERS FOR POLYMER NETWORKS | CIBA HOLDING INC (CH) | 2008-11-26 | — | — | EP | disclosed |
| EP-1451248-B1 | 2-HYDROXYPHENYL-S-TRIAZINE CROSSLINKERS FOR POLYMER NETWORKS | CIBA HOLDING INC (CH) | 2008-11-26 | — | — | EP | disclosed |
| US-7214742-B2 | 2-hydroxyphenyl-s-triazine crosslinkers for polymer networks | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-05-08 | — | — | US | disclosed |
| US-7214742-B2 | 2-hydroxyphenyl-s-triazine crosslinkers for polymer networks | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-05-08 | — | — | US | disclosed |
| US-7214742-B2 | 2-hydroxyphenyl-s-triazine crosslinkers for polymer networks | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-05-08 | — | — | US | disclosed |
| US-20050075465-A1 | 2-Hydroxyphenyl-s-triazine crosslinkers for polymer networks | CIBA SPECIALTY CHEMICALS CORPORATION | 2005-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075465-A1 | 2-Hydroxyphenyl-s-triazine crosslinkers for polymer networks | H1-5, SMC4, H1-4 | L3MBTL1 1019/4885NR1I2 1706/4885ALDH2 3660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.